Nutrien Ltd. Q2 2026 Earnings Recap

Nutrien's shares declined modestly (-0.6%) as investors digested a mixed quarter featuring raised potash volume guidance but ongoing margin pressure in nitrogen and cautious outlook commentary on global urea prices amid geopolitical uncertainty.

Key Takeaways

• Q2 adjusted EBITDA reached $2.4 billion, with first half EBITDA up 6% year-over-year; cash flow from operations grew 12% in H1.
• Potash volumes hit record levels, with the company raising the bottom end of 2026 potash sales guidance and maintaining a controllable cash cost target below $60/tonne.
• Proprietary Products margins expanded 10% despite softer overall fertilizer demand, supported by targeted capacity investments and a nearly tenfold increase in select nutritional product sales volumes.
• Nitrogen segment faced headwinds from seasonal urea price declines and geopolitical factors, though North American assets benefit from low-cost natural gas and recent operational improvements.
• Portfolio optimization progressed with $90 million of non-core asset sales agreements signed and ongoing strategic reviews of phosphate, Trinidad nitrogen, and Brazilian retail businesses.